Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...

Strategies for Assessing and Addressing Confounding

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

Mechanistic Models: Overview of Compartment Models

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advancing occupational exposure models: insights from a case study.

Annals of work exposures and health·2026

Same author

Innovative oncology trial designs: Time to act - A review with recommendations of the Cancer Drug Development Forum.

Journal of cancer policy·2025

Same author

A Nano Risk Governance Portal supporting risk governance of nanomaterials and nano-enabled products.

Computational and structural biotechnology journal·2025

Same author

The Nano Exposure Quantifier: a quantitative model for assessing nanoparticle exposure in the workplace.

Annals of work exposures and health·2025

Same author

Development of a nano-specific safe-by-design module to identify risk management strategies.

Annals of work exposures and health·2024

Same author

Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.

Journal for immunotherapy of cancer·2024

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

Stoffenmanager exposure model: company-specific exposure assessments using a Bayesian methodology.

Peter van de Ven¹, Wouter Fransman, Jody Schinkel

¹Business Unit Quality & Safety, TNO Quality of Life, Zeist, The Netherlands.

Journal of Occupational and Environmental Hygiene

|February 11, 2010

Summary

A new Bayesian method enhances the Stoffenmanager tool for quantitative workplace exposure assessment. It combines existing estimates with company-specific data, improving risk assessment for small businesses.

More Related Videos

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Published on: January 12, 2024

Related Experiment Videos

Last Updated: Jun 16, 2026

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System

Published on: January 12, 2024

Area of Science:

Occupational Health and Safety
Exposure Science
Bayesian Statistics

Background:

The Stoffenmanager tool aids small and medium-sized enterprises (SMEs) in qualitative workplace risk assessment.
The tool employs a mechanistic model to generate exposure scores, but substantial variability remains.
Existing models struggle with sparse data common in SMEs.

Purpose of the Study:

To introduce a Bayesian methodology extension for quantitative, company-specific exposure assessment.
To integrate real exposure data with the Stoffenmanager model's prior estimates.
To enhance risk assessment accuracy, particularly for data-limited scenarios in SMEs.

Main Methods:

Developed a Bayesian approach to combine prior exposure estimates with observed company data.
Applied the methodology to quantitative workplace/scenario-specific exposure assessment.
Utilized real-world examples and simulation studies to evaluate the model's performance.

Main Results:

The Bayesian extension provides company-specific exposure level assessments.
The approach transparently synthesizes diverse information sources.
The posterior distribution is influenced by sample size, prior-data differences, and data variance.

Conclusions:

The Bayesian approach offers a robust method for quantitative exposure assessment in SMEs.
It effectively addresses data scarcity by combining prior knowledge with empirical evidence.
This enhances the reliability of workplace risk assessments for targeted control strategies.